1612891-76-5

Basic information

• Product Name: 5,7-dimethoxy-2-(4-(2-piperidin-1-ylethoxy)phenyl)chromen-4-one
• Synonyms: 5,7-dimethoxy-2-(4-(2-piperidin-1-ylethoxy)phenyl)chromen-4-one
• CAS NO: 1612891-76-5
• Molecular Weight: 409.482
• Mol File: 1612891-76-5.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 5,7-dimethoxy-2-(4-(2-piperidin-1-ylethoxy)phenyl)chromen-4-one(CAS DataBase Reference)
• NIST Chemistry Reference: 5,7-dimethoxy-2-(4-(2-piperidin-1-ylethoxy)phenyl)chromen-4-one(1612891-76-5)
• EPA Substance Registry System: 5,7-dimethoxy-2-(4-(2-piperidin-1-ylethoxy)phenyl)chromen-4-one(1612891-76-5)

Safety Data

• Hazardous Substances Data: 1612891-76-5(Hazardous Substances Data)

Upstream product

• 16290-50-9 3-(4-hydroxyphenyl)-5,7-dimethoxy-4H-chromen-4-one 
• 40663-68-1 4-(2-propenyloxy)benzaldehyde 
• 110-89-4 piperidine 
• 1612891-70-9 2-(4-(2-bromoethoxy)phenyl)-5,7-dimethoxychromen-4-one 
• 1167577-15-2 C₂₀H₁₈O₅ 
• 76554-28-4 C₂₀H₂₀O₅ 
• 90-24-4 2-hydroxy-4,6-dimethoxyacetophenone 

Relevant articles and documents

APIGENIN ANALOGS, COMPOSITIONS, AND METHODS RELATED THERETO

Certain embodiments are directed to apigenin analogues or derivatives. In certain aspects, the derivatives are developed as cystathionine-beta-synthase (CBS) inhibitors. In certain aspects, the derivatives are used as anticancer or anti-inflammatory agents. Certain embodiments are directed methods of treating or compositions used to treat fibrosis and cancers. In certain aspects one or more compounds described herein can be administered to a subject to treat pancreatic fibrosis, liver fibrosis, pancreatic cancer, colon cancer, breast cancer, brain tumors, head/neck cancer, prostate and lung cancers as well as other inflammation.